
AnaptysBio, Inc.
AnaptysBio, Inc.(ANAB)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · ANAB · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
46
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
AnaptysBio, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ANAB 季度内部人买卖趋势
ANAB 内幕交易卖出 · ANAB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ANAB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ANAB 高管卖出股份 · ANAB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 30, 2026 | Schmid John P. Director | Sale | 12,596 | $702K | Form 4 |
| Mar 30, 2026 | Schmid John P. Director | Sale | 7,527 | $427K | Form 4 |
| Mar 30, 2026 | Schmid John P. Director | Sale | 522 | $30K | Form 4 |
| Mar 25, 2026 | Faga Daniel President, CEO · Director | Award | 34,300 | — | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 510 | $29K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 2,570 | $149K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,662 | $215K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 490 | $29K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 550 | $33K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 1,012 | $63K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 2,592 | $164K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,155 | $203K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 3,038 | $198K | Form 4 |
| Mar 27, 2026 | Faga Daniel President, CEO · Director | Sale | 100 | $7K | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option | 10,000 | $297K | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale | 10,000 | $540K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Option | 11,000 | $287K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Sale | 9,290 | $447K | Form 4 |
| Jan 15, 2026 | Marquet Magda Director | Sale | 1,710 | $84K | Form 4 |
| Jan 7, 2026 | Lizzul Paul F. Chief Medical Officer | Option | 8,525 | — | Form 4 |
| Jan 8, 2026 | Lizzul Paul F. Chief Medical Officer | Sale | 3,650 | $163K | Form 4 |
| Jan 7, 2026 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option | 6,700 | — | Form 4 |
| Jan 8, 2026 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | 2,515 | $112K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option | 5,888 | — | Form 4 |
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ANAB 内幕交易
ANAB 内幕交易
AnaptysBio, Inc.(ANAB)内幕交易数据来源于公司内部人(包括Faga Daniel (President, CEO · Director), Schmid John P. (Director), LOUMEAU ERIC J (CHIEF LEGAL OFFICER))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。ANAB内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看AnaptysBio, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
ANAB 内幕交易 · 5个问题AnaptysBio, Inc.(ANAB)的内部人包括高管和董事,如Faga Daniel (President, CEO · Director), Schmid John P. (Director), LOUMEAU ERIC J (CHIEF LEGAL OFFICER)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026